Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
While GLP-1 medications produce weight loss primarily through appetite mechanisms, their anti-inflammatory properties in other disease contexts suggest potential direct skin benefits
Berberine may affect blood glucose levels and could potentially interact with antidiabetic medications, increasing the risk of hypoglycaemia
This emerging mechanism substantially expands our understanding of SFNs anticancer portfolio, particularly against therapy-resistant malignancies
Scyllo-inositol showed no activity (Fig
US$ 20.41
US$ 29.48
US$ 28.08
